Development of anti-microbial medicines from nitric oxide
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | DAVID GENCARELLI |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | |
| 2024 | DAVID GENCARELLI |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | DAVID GENCARELLI |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | DAVID GENCARELLI |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2023 | DAVID GENCARELLI |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2023 | DAVID GENCARELLI |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2023 | DAVID GENCARELLI |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2022 | DAVID GENCARELLI |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2022 | DAVID GENCARELLI |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| DAVID GENCARELLI | 9 | — |
| Issue | Activities |
|---|---|
| Health Issues | 9 |
| Medical/Disease Research/Clinical Labs | 8 |
| Budget/Appropriations | 8 |